BIOMAT Database Logo BIOMAT Database Logo

A highly selective kappa-opioid receptor agonist with low addictive potential and dependence liability. 2006

Hee Sock Park, and Hee Yoon Lee, and Yong Hae Kim, and Jin Kyu Park, and Edwin E Zvartau, and Heeseung Lee
Department of Chemistry, KAIST, Daejeon 305-701, Republic of Korea.

Buprenorphine analogs have been synthesized. In the studies of analgesic and addictive effects in mice and [(35)S]GTPgammaS binding assay in human brain tissue, an analog of buprenorphine where the tert-butyl is replaced by a cyclobutyl moiety (16) has been identified as a selective kappa-partial agonist which gives antinociceptive effects, but has low abuse potential. The results may lead to lower degrees of dysphoria than full kappa-agonists.

UI MeSH Term Description Entries
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D002047 Buprenorphine A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use. 6029-M,Buprenex,Buprenorphine Hydrochloride,Buprex,Prefin,RX-6029-M,Subutex,Temgesic,Temgésic,6029 M,6029M,Hydrochloride, Buprenorphine,RX 6029 M,RX6029M
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Hee Sock Park, and Hee Yoon Lee, and Yong Hae Kim, and Jin Kyu Park, and Edwin E Zvartau, and Heeseung Lee
Salvinorin A: a novel and highly selective kappa-opioid receptor agonist.
October 2004, Life sciences,
Hee Sock Park, and Hee Yoon Lee, and Yong Hae Kim, and Jin Kyu Park, and Edwin E Zvartau, and Heeseung Lee
LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
April 2008, European journal of pharmacology,
Hee Sock Park, and Hee Yoon Lee, and Yong Hae Kim, and Jin Kyu Park, and Edwin E Zvartau, and Heeseung Lee
Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.
July 1991, British journal of pharmacology,
Hee Sock Park, and Hee Yoon Lee, and Yong Hae Kim, and Jin Kyu Park, and Edwin E Zvartau, and Heeseung Lee
PD117302: a selective agonist for the kappa-opioid receptor.
March 1988, British journal of pharmacology,
Hee Sock Park, and Hee Yoon Lee, and Yong Hae Kim, and Jin Kyu Park, and Edwin E Zvartau, and Heeseung Lee
[Central depressor effect of U50488H: a highly selective kappa opioid agonist].
June 1987, Sheng li xue bao : [Acta physiologica Sinica],
Hee Sock Park, and Hee Yoon Lee, and Yong Hae Kim, and Jin Kyu Park, and Edwin E Zvartau, and Heeseung Lee
N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
January 2008, The Journal of pharmacology and experimental therapeutics,
Hee Sock Park, and Hee Yoon Lee, and Yong Hae Kim, and Jin Kyu Park, and Edwin E Zvartau, and Heeseung Lee
Ischemic neuroprotection with selective kappa-opioid receptor agonist is gender specific.
July 2005, Stroke,
Hee Sock Park, and Hee Yoon Lee, and Yong Hae Kim, and Jin Kyu Park, and Edwin E Zvartau, and Heeseung Lee
5'-Guanidinonaltrindole, a highly selective and potent kappa-opioid receptor antagonist.
May 2000, European journal of pharmacology,
Hee Sock Park, and Hee Yoon Lee, and Yong Hae Kim, and Jin Kyu Park, and Edwin E Zvartau, and Heeseung Lee
CI-977, a novel and selective agonist for the kappa-opioid receptor.
September 1990, British journal of pharmacology,
Hee Sock Park, and Hee Yoon Lee, and Yong Hae Kim, and Jin Kyu Park, and Edwin E Zvartau, and Heeseung Lee
Bimorphinans as highly selective, potent kappa opioid receptor antagonists.
February 1987, Journal of medicinal chemistry,
Copied contents to your clipboard!